A critical advance in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently lost in various types of malignancies, leading https://wearethelist.com/story24154516/mini-antibodies-revive-p53-the-potential-hope-for-tumor-treatment